Development and Implementation of an Advanced Program for Robotic Treatment of Prostate Cancer-Is Surgical Quality Transferable?

implementation science postoperative complications prostatectomy prostatic neoplasm robotics treatment outcome

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
26 Oct 2022
Historique:
received: 10 09 2022
revised: 21 10 2022
accepted: 23 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 12 11 2022
Statut: epublish

Résumé

Introduction: Robot-assisted radical prostatectomy (RARP) is a surgical treatment option for prostate cancer (PC). Quality in RARP depends on the surgeon´s operative volume and expertise. When implementing RARP, it is standard practice to hire a pre-trained surgeon. The aim of our study was to investigate the transferability of quality in RARP. Patients and Methods: We analyzed two consecutive retrospective cohorts of 100 and 108 men, respectively, who underwent RARP at two different centers and on whom surgery was performed by the same surgeon. Results: There were more men with high-grade PC in Cohort 1: 25/100 (25.0%) vs. 9/108 (8.3%), p < 0.01, and infiltration of the seminal vesicles was more frequent (23/100 (23.0%) vs. 10/108 (9.2%), p < 0.01). In Cohort 2, the duration of surgery was shorter and blood loss was lower: 149 (134−174) vs. 172 min (150−196), p < 0.01 and 300 (200−400) vs. 131 (99−188) mL, p < 0.01. No difference was found in the proportion of positive surgical margins in the T2 cohort (8.8% vs. 8.2%, p = 1.00). Conclusion: The procedural and oncological outcome parameters of Cohort 2 do not appear to be inferior to the results obtained for the first cohort. The quality of RARP is transferable if a pre-trained surgeon is hired.

Identifiants

pubmed: 36358680
pii: cancers14215261
doi: 10.3390/cancers14215261
pmc: PMC9657656
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Health Technol Assess. 2012;16(41):1-313
pubmed: 23127367
J Robot Surg. 2022 Dec;16(6):1451-1461
pubmed: 35226289
Eur Urol. 2016 May;69(5):917-23
pubmed: 26578444
Eur Urol. 2017 Jul;72(1):84-109
pubmed: 28126351
Can Urol Assoc J. 2021 Oct;15(10):E531-E544
pubmed: 33750517
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Transl Androl Urol. 2021 May;10(5):2151-2157
pubmed: 34159097
Eur Urol. 2012 Sep;62(3):382-404
pubmed: 22749851
World J Urol. 2022 Apr;40(4):929-949
pubmed: 34480591
Eur Urol. 2012 Sep;62(3):431-52
pubmed: 22749853
Minerva Urol Nephrol. 2022 Apr;74(2):133-136
pubmed: 35345386

Auteurs

August Sigle (A)

Department of Urology, Faculty of Medicine, Medical Centre, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.
Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, 79085 Freiburg, Germany.

Cordula A Jilg (CA)

Department of Urology, Faculty of Medicine, Medical Centre, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.

Moritz Weishaar (M)

Department of Urology, Faculty of Medicine, Medical Centre, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.

Boris Schlenker (B)

Department of Urology, Ludwig-Maximilians-University of Munich, 80539 Munich, Germany.

Christian Stief (C)

Department of Urology, Ludwig-Maximilians-University of Munich, 80539 Munich, Germany.

Christian Gratzke (C)

Department of Urology, Faculty of Medicine, Medical Centre, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.

Markus Grabbert (M)

Department of Urology, Faculty of Medicine, Medical Centre, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.

Classifications MeSH